Brain Biomarkers in Patients with COVID-19 and Neurological Manifestations: A Narrative Review

Abstract: Acute hyperinflammatory response (cytokine storm) and immunosuppression are responsible for critical illness in patients infected with coronavirus disease 2019 (COVID-19). It is a serious public health crisis that has affected millions of people worldwide. The main clinical manifestations are mostly by respiratory tract involvement and have been extensively researched. Increasing numbers of evidence from emerging studies point out the possibility of neurological involvement by COVID-19 highlighting the need for developing technology to diagnose, manage, and treat brain injury in such patients. Here, we aimed to discuss the rationale for the use of an emerging spectrum of blood biomarkers to guide future diagnostic strategies to mitigate brain injury-associated morbidity and mortality risks in COVID-19 patients, their use in clinical practice, and prediction of neurological outcomes.

Object Details

• Location: Deutsche Nationalbibliothek Frankfurt am Main
• Extent: Online-Ressource
• Language: Englisch

References and Relationships

• Bibliographic citation: Brain Biomarkers in Patients with COVID-19 and Neurological Manifestations: A Narrative Review ; volume:09 ; number:01 ; year:2022 ; pages:010-015 ; Journal of neuroanaesthesiology and critical care ; 09, Heft 01 (2022), 010-015

Contributors, Places and Time

• Contributor: Tyagi, Mayank ; Kapoor, Indu ; Mahajan, Charu ; Gupta, Nidhi ; Prabhakar, Hemanshu

Further information

• DOI: 10.1055/s-0042-1744395
• URN: urn:nbn:de:101:1-2022071412204478473203
• Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
• Last update: 15.08.2025, 7:28 AM CEST